<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel>
        <title>kerostig | Tag : risk valuation</title>
        <link>https://kerostig.org/tag/risk-valuation/</link>
        <description>Derniers appels à publications avec le tag 'risk valuation'.</description>
        <lastBuildDate>Tue, 17 Nov 2026 23:14:11 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>https://github.com/jpmonette/feed</generator>
        <language>fr</language>
        <image>
            <title>kerostig | Tag : risk valuation</title>
            <url>https://kerostig.org/public/favicon/android-chrome-96x96.png</url>
            <link>https://kerostig.org/tag/risk-valuation/</link>
        </image>
        <copyright>Notices : kerostig © 2026. Le texte des appels appartient à leurs éditeurs.</copyright>
        <item>
            <title><![CDATA[Valuing health and longevity: Advances and innovations]]></title>
            <link>https://kerostig.org/call/springer-by-invitation-only-valuing-health-and-longevity-advances-and-innovations/</link>
            <guid>springer-by-invitation-only-valuing-health-and-longevity-advances-and-innovations</guid>
            <pubDate>Tue, 11 Aug 2026 21:25:02 GMT</pubDate>
            <content:encoded><![CDATA[
<div>
    
        
        <p><strong>Olof Bystrom</strong>, OECD</p>
        
        <p><strong>Ståle Navrud</strong>, Norwegian University of Life Sciences</p>
        
        <p><strong>Lisa A. Robinson</strong>, Harvard T.H. Chan School of Public Health</p>
        
    
    
    
    <p>Mortality risk valuations are central to assessing the benefits of environmental policies, but the research base on value per statistical life contains significant gaps and inconsistencies. There is insufficient evidence on how population characteristics and risk properties influence these values, and synthesizing results across studies remains challenging. Nonfatal health impacts, while often substantial, receive comparatively less research attention and are frequently valued using indirect cost-based approaches rather than direct willingness-to-pay measures.</p>
    
    <p>The collection addresses emerging research that tackles these limitations through improved valuation methodologies for both mortality and morbidity risks, refined techniques for combining and transferring estimates across contexts, and innovations addressing equity considerations in benefit assessment. This special issue serves as a reference for researchers and practitioners working on the economic valuation of health effects in environmental policy analysis.</p>
    
    <p>
        Appel publié par Environmental and Resource Economics.
        
        <a href="https://link.springer.com/collections/gdbbbihied">Voir l'appel sur le site de l'éditeur</a>.
        
        <a href="https://kerostig.org/call/springer-by-invitation-only-valuing-health-and-longevity-advances-and-innovations/">Fiche de l'appel sur kerostig</a>.
    </p>
    
    <h2>Potential topics</h2>
    <ul>
        
        <li>Value per statistical life (VSL)</li>
        
        <li>Willingness to pay (WTP) for mortality risk reductions</li>
        
        <li>Nonfatal risk reductions and morbidity valuation</li>
        
        <li>Population and risk attributes affecting valuations</li>
        
        <li>Benefit transfer and meta-analysis methods</li>
        
        <li>Health impact economic valuation</li>
        
        <li>Environmental policy benefit estimation</li>
        
        <li>Equity and distributional concerns in valuation</li>
        
        <li>Best practice approaches for health valuation</li>
        
    </ul>
    
    
    <h2>Timeline</h2>
    <ul>
        
        <li>November 30, 2026: Submission deadline</li>
        
    </ul>
    
    
</div>
]]></content:encoded>
        </item>
    </channel>
</rss>